Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EF-M2 in Moderate-to-Severe Rheumatoid Arthritis
NCT07349420Phase 2Completed
- Sponsor
- S-LAB
- Start
- Jun 2025
- Primary completion
- Oct 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of EF-M2 in rheumatoid arthritis (RA), sponsored by S-LAB. Started Jun 2025; status: completed.
02
Drugs
EF-M2
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07349420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349420.